Sustainability Report

Overview

The report describes Daewoong Pharmaceutical's 2024 sustainability strategy and performance across environmental, social, and governance topics. Highlights include a double materiality assessment identifying four key issues, group-level ESG governance, climate and resource-management initiatives, and extensive workforce and workplace-safety disclosures. The report also presents consolidated environmental data, including Scope 1 and 2 emissions, energy, water, and waste metrics, alongside social contribution and human-rights activities. An independent assurance statement provides limited assurance over selected GRI-related disclosures.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2025
Period: 1 January 2024 – 31 December 2024
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services

Overview